home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Marrone Bio Innovations' seed treatments demonstrate improved yields and cost-effective control - Trials conducted internationally by Marrone Bio and its wholly owned subsidiary, Pro Farm Technologies OY


Davis, California, USA
December 9, 2019

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced today that its 2019 field trial results for biology-based seed treatments in Europe demonstrated improved yields and cost-effective control of soil insects and nematodes that are equivalent to or better than current industry standards. 

Additionally, the company’s wholly owned subsidiary, Pro Farm Technology OY (Pro Farm), has demonstrated significant benefits to growers when its patented Foraminâ nutrient technology is used in conjunction with conventional or biology-based seed treatments.  Foramin offers growers enhanced plant physiology, reduced plant stress, and improved yields and crop quality. 

Results from recent yield and stress tolerance trials will be presented by Kalle Virta, director of research and development for Pro Farm, at the “Exceed The Seed” event during the American Seed Trade Association meeting on December 9, 2019 in Chicago, Illinois.

“The past growing season marked our first international tests — including in the European Union — of the Marrone Bio suite of seed- and soil-applied products,” said Chief Commercial Officer Kevin Hammill.  “These bioprotection products complement Pro Farm’s existing portfolio of plant health products. With Pro Farm’s broad international distribution capabilities, we expect to bring to more growers the benefits of MBI’s technology and broad bioprotection product portfolio.”

Marrone Bio’s and Pro Farm’s family of seed and soil treatment products are currently available to growers through its distribution and seed company partners in the United States, Canada, Uruguay and Europe with near term expansion into India, Australia, Brazil, Argentina, Paraguay, Bolivia and CIS region for use in a wide variety of crops including corn, soybean, cotton, wheat, barley, sunflower, oilseed rape and vegetables.

MBI European Seed Treatment Field Trial Results

Corn seed treatment trials testing MBI-203 and MBI-206 for corn root worm and nematode control showed yield gains against both the untreated control and a currently used chemical option.  When compared with the current treatment, yield gains as high as 35 percent were observed when used at commercial application rates.

 

Ercole® is a registered trademark of Sipcam

 



Nemathorin® is a registered trademark of Syngenta

 

Pro Farm Stress-Tolerance Greenhouse and Field Trial Results

Pro Farm tested its Foramin products for 18 different stress parameters across multiple growth stages for barley and wheat in both greenhouse and field conditions in Europe throughout 2019.  Foramin is designed to be used in combination with a standard conventional seed treatment package.  The Foramin products include both a seed treatment and a foliar applied product.

Last season’s results from barley and wheat field trials in Latin America showed yield increases in barley ranging from 2.1 percent to 6.7 percent; and in wheat from 9.0 percent to 14.3 percent.  At current commodity prices, these yield gains would add approximately $8 to $26 per acre in revenue for barley growers, and approximately $44 to $68 per acre in revenue for wheat growers.

 

 

 

 

About Marrone Bio Innovations    

Marrone Bio Innovations Inc. (NASDAQ: MBII) is a growth-oriented company leading the movement to a more sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment that help customers operate more sustainably while increasing their return on investment. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry to rapidly develop seven product lines. Supported by a robust portfolio of over 400 issued and pending patents, MBI’s currently available commercial products are Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven® and Amplitude®, Zelto® Jet Oxide® and Jet Ag® and Zequanox®, with a breakthrough bioherbicide and biofumigant in the Company’s product pipeline. MBI also recently completed the acquisition of Pro Farm Finland-based Pro Farm’s technology employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality.

Learn more about Marrone Bio Innovations at www.marronebio.com. We also use our investor relations website, https://investors.marronebio.com, as well as our corporate Twitter account, @Marronebio, as means of disclosing material non-public information, and encourage our investors and others to monitor and review the information we make public in these locations. Follow us on social media: Twitter, LinkedIn and Instagram.



More news from:
    . Marrone Bio Innovations
    . Pro Farm Technologies OY


Website: http://marronebioinnovations.com/

Published: December 9, 2019

The news item on this page is copyright by the organization where it originated
Fair use notice

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

  Archive of the news section

 

 


Copyright @ 1992-2024 SeedQuest - All rights reserved